lilly tirzepatide lawsuit Novo Nordisk, maker of the popular medications Ozempic and Wegovy, filed a Tuesday against the pharmaceutical company Eli Lilly, accusing it of making deceptive advertising claims about its weight-loss drug Zepbound Eli Lilly Files Slew of

Most patients notice the first signs of appetite suppression and reduced food cravings within 37 days of starting tirzepatide

According to WHO data, global obesity prevalence has nearly tripled since 1975, and more than 650 million adults are currently obese

GLP-1 use continues to rise with 12.4% of US consumers now on the weight loss drug, up from 5.8% in 2024, according to a recent white paper by The Hartman Group

Discover Glutone 1000 At Glutone, we merge science and beauty to enhance your skin's natural radiance with the best ingredients and formulations

Talk with your provider about whether HRT could be right for you

This is true